Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Peripheral T-cell Lymphoma”

61 trials

Showing 20 of 61 results

Testing effectiveness (Phase 2)UnknownNCT00840385
What this trial is testing

Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL)

Who this might be right for
T-Cell LymphomasChemotherapy
Fudan University 30
Not applicableLooking for participantsNCT05662540
What this trial is testing

PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma

Who this might be right for
NK/T-cell Lymphoma
Ruijin Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06824883
What this trial is testing

Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma
Peking Union Medical College Hospital 49
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Testing effectiveness (Phase 2)Looking for participantsNCT06583083
What this trial is testing

Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Sun Yat-sen University 84
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00930605
What this trial is testing

The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-cell Lymphoma
King Chulalongkorn Memorial Hospital 16
Testing effectiveness (Phase 2)Ended earlyNCT02520479
What this trial is testing

"Sandwich" Chemotherapy With Radiotherapy in Newly Diagnosed, Stage IE to IIE, ENKTL

Who this might be right for
Treatment Refusal
Sun Yat-sen University 12
Testing effectiveness (Phase 2)Study completedNCT00290433
What this trial is testing

Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 55
Testing effectiveness (Phase 2)Looking for participantsNCT06739265
What this trial is testing

Golidocitinib Plus CHOP in Newly Diagnosed PTCL

Who this might be right for
Peripheral T-cell Lymphoma
Peking Union Medical College Hospital 68
Large-scale testing (Phase 3)Not Yet RecruitingNCT06255795
What this trial is testing

The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma

Who this might be right for
Extranodal Natural Killer T Cell Lymphoma
Ruijin Hospital 142
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Large-scale testing (Phase 3)Looking for participantsNCT06947967
What this trial is testing

Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Who this might be right for
Lymphoma, T-Cell, Peripheral
Chipscreen Biosciences, Ltd. 224
Post-approval studies (Phase 4)UnknownNCT03071822
What this trial is testing

Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas

Who this might be right for
Peripheral T Cell Lymphoma
The University of Hong Kong 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04127227
What this trial is testing

Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type

Who this might be right for
NK/T Cell Lymphoma Nos
Sun Yat-sen University 34
Testing effectiveness (Phase 2)UnknownNCT04480099
What this trial is testing

Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Ruijin Hospital 96
Large-scale testing (Phase 3)Looking for participantsNCT06072131
What this trial is testing

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Acrotech Biopharma Inc. 504
Not applicableUnknownNCT05896813
What this trial is testing

CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Who this might be right for
Newly Diagnosed Peripheral T-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 30
Large-scale testing (Phase 3)Study completedNCT00970385
What this trial is testing

Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
University Hospital, Grenoble 95
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07574528
What this trial is testing

A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma

Who this might be right for
NKTCL
Sun Yat-sen University 47
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation